{"transactions":[{"id":2098466,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":121914,"kind":"person","name":"Stants Kristen","position":1,"cik":"0001805727","reported_name":"Stants Kristen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2022-12-02T16:19:27.000Z","date":"2022-11-30","kind":"grant","acquired":true,"shares":3000,"price":0.94,"value":2820.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Magenta Therapeutics, Inc. 2019 Employee Stock Purchase Plan (the \"ESPP\") for the ESPP purchase period of June 1, 2022 through November 30, 2022. This transaction is exempt under both Rule 16b-3(c) and Rule 16b-3(d)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on June 1, 2022."}],"balance_after":20264,"source":{"system":"sec-edgar","filing":"0000899243-22-037424","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805727/000089924322037424/doc4.xml","form_type":"4"}},{"id":2199121,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":121914,"kind":"person","name":"Stants Kristen","position":1,"cik":"0001805727","reported_name":"Stants Kristen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-08-01T21:11:01.000Z","date":"2022-08-01","kind":"grant","acquired":true,"shares":85000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in 16 equal quarterly installments beginning on the first quarter following the vesting commencement date. The vesting commencement date is August 1, 2022."}],"balance_after":85000,"derivative":{"exercise_price":1.57,"expiration_date":"2032-07-31","underlying":"Common Stock","underlying_shares":85000},"source":{"system":"sec-edgar","filing":"0000899243-22-027265","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805727/000089924322027265/doc4.xml","form_type":"4"}},{"id":2242541,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":121914,"kind":"person","name":"Stants Kristen","position":1,"cik":"0001805727","reported_name":"Stants Kristen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2022-06-06T16:06:01.000Z","date":"2022-05-31","kind":"grant","acquired":true,"shares":3000,"price":0.99,"value":2970.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Magenta Therapeutics, Inc. 2019 Employee Stock Purchase Plan (the \"ESPP\") for the ESPP purchase period of December 1, 2021 through May 31, 2022. This transaction is exempt under both Rule 16b-3(c) and Rule 16b-3(d)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on May 31, 2022."}],"balance_after":17264,"source":{"system":"sec-edgar","filing":"0000899243-22-021186","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805727/000089924322021186/doc4.xml","form_type":"4"}},{"id":2263915,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":121914,"kind":"person","name":"Stants Kristen","position":1,"cik":"0001805727","reported_name":"Stants Kristen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-19T16:22:19.000Z","date":"2022-05-17","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in three equal installments, each installment vesting every six months, over the 18 months following the vesting commencement date. The vesting commencement date is May 15, 2022."}],"balance_after":50000,"derivative":{"exercise_price":1.18,"expiration_date":"2032-05-16","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000899243-22-018812","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805727/000089924322018812/doc4.xml","form_type":"4"}},{"id":2388751,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":121914,"kind":"person","name":"Stants Kristen","position":1,"cik":"0001805727","reported_name":"Stants Kristen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-17T17:20:55.000Z","date":"2022-02-15","kind":"grant","acquired":true,"shares":85000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in 16 equal quarterly installments beginning on the first quarter following the vesting commencement date. The vesting commencement date is February 1, 2022."}],"balance_after":85000,"derivative":{"exercise_price":3.19,"expiration_date":"2032-02-14","underlying":"Common Stock","underlying_shares":85000},"source":{"system":"sec-edgar","filing":"0000899243-22-006820","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805727/000089924322006820/doc4.xml","form_type":"4"}},{"id":2564142,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":121914,"kind":"person","name":"Stants Kristen","position":1,"cik":"0001805727","reported_name":"Stants Kristen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2021-09-20T17:08:51.000Z","date":"2021-09-16","kind":"sale","acquired":false,"shares":5736,"price":6.73,"value":38603.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction represents shares sold solely to pay taxes due upon the vesting of restricted stock units, as disclosed by the reporting person on the Form 4 filed on September 16, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.60 to $6.87, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":14264,"source":{"system":"sec-edgar","filing":"0000899243-21-036604","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805727/000089924321036604/doc4.xml","form_type":"4"}},{"id":2567830,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":121914,"kind":"person","name":"Stants Kristen","position":1,"cik":"0001805727","reported_name":"Stants Kristen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2021-09-16T19:42:32.000Z","date":"2021-09-14","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On October 26, 2020, the reporting person was granted 40,000 restricted stock units. The restricted stock units vest in two equal installments subject to the achievement of certain performance milestones related to the issuer's business plans. The first performance milestone was achieved, resulting in vesting of 20,000 restricted stock units and the corresponding issuance of 20,000 shares of issuer common stock."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0000899243-21-036341","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805727/000089924321036341/doc4.xml","form_type":"4"}},{"id":2617957,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":121914,"kind":"person","name":"Stants Kristen","position":1,"cik":"0001805727","reported_name":"Stants Kristen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-08-03T16:34:45.000Z","date":"2021-08-02","kind":"grant","acquired":true,"shares":67500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in 16 equal quarterly installments beginning on August 2, 2021."}],"balance_after":67500,"derivative":{"exercise_price":7.11,"expiration_date":"2031-08-01","underlying":"Common Stock","underlying_shares":67500},"source":{"system":"sec-edgar","filing":"0000899243-21-031274","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805727/000089924321031274/doc4.xml","form_type":"4"}},{"id":2859484,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":121914,"kind":"person","name":"Stants Kristen","position":1,"cik":"0001805727","reported_name":"Stants Kristen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-16T17:42:49.000Z","date":"2021-02-11","kind":"grant","acquired":true,"shares":67500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in 16 equal quarterly installments beginning on January 1, 2021."}],"balance_after":67500,"derivative":{"exercise_price":10.8,"expiration_date":"2031-02-10","underlying":"Common Stock","underlying_shares":67500},"source":{"system":"sec-edgar","filing":"0000899243-21-006705","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805727/000089924321006705/doc4.xml","form_type":"4"}}]}